Chemoinformaics analysis of Hexadecahydrocyclobuta[1,2:3,4]dicyclooctene
| Molecular Weight | 220.4 | nRot | 0 |
| Heavy Atom Molecular Weight | 192.176 | nRig | 18 |
| Exact Molecular Weight | 220.219 | nRing | 3 |
| Solubility: LogS | -6.829 | nHRing | 0 |
| Solubility: LogP | 6.619 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 45.3902 |
| nHD | 0 | BPOL | 28.0898 |
| QED | 0.528 |
| Synth | 1.775 |
| Natural Product Likeliness | 0.314 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.736 |
| MDCK | 0.0000123 |
| BBB | 0.027 |
| PPB | 0.963969 |
| VDSS | 3.058 |
| FU | 0.00776427 |
| CYP1A2-inh | 0.072 |
| CYP1A2-sub | 0.233 |
| CYP2c19-inh | 0.458 |
| CYP2c19-sub | 0.129 |
| CYP2c9-inh | 0.17 |
| CYP2c9-sub | 0.602 |
| CYP2d6-inh | 0.513 |
| CYP2d6-sub | 0.08 |
| CYP3a4-inh | 0.183 |
| CYP3a4-sub | 0.19 |
| CL | 5.178 |
| T12 | 0.033 |
| hERG | 0.089 |
| Ames | 0.01 |
| ROA | 0.134 |
| SkinSen | 0.941 |
| Carcinogencity | 0.042 |
| EI | 0.987 |
| Respiratory | 0.375 |
| NR-Aromatase | 0.046 |
| Antiviral | Yes |
| Prediction | 0.828572 |